Photobiomodulation, the clinical name for low-level laser therapy, has a real research base, but it is uneven. In some areas the evidence is genuinely strong. In others it is early, thin, or mixed. This article walks through both, without tilting the picture in either direction, so that a cautious reader can decide what the science does and does not support. If you want the whole blog to be worth trusting, this is the page where we prove it.
What Photobiomodulation Is, In Plain Terms
Photobiomodulation (PBM) uses low-intensity red and near-infrared light to influence cells. It does not cut, heat, or break the skin, which is why it is sometimes called cold laser therapy. The light is absorbed inside cells by an enzyme in the mitochondria, and that interaction is thought to nudge cellular energy production and signalling. If you want the mechanism in everyday language, we cover it in what cold laser therapy is, in plain language, and in more molecular detail in how photobiomodulation repairs neurotransmitter pathways.
That mechanism is well described. The important thing to understand is that a plausible mechanism is not the same as a proven outcome. A treatment can affect a cell in a laboratory and still fail to change what a patient experiences in real life. So the honest question is not "does light do something to cells," which it clearly does, but "for which conditions has that translated into a measurable clinical benefit, and how confident can we be." Those are different questions, and they have different answers depending on the condition.
Where the Evidence Is Stronger
The strongest single body of evidence for photobiomodulation is in oral mucositis, the painful mouth ulceration that many cancer patients develop from chemotherapy and radiation. Here the research has matured past small one-off trials into pooled reviews and formal clinical guidelines.
A systematic review by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology (MASCC/ISOO) examined the trial literature and issued guidelines recommending photobiomodulation to prevent oral mucositis in specific settings, including adults receiving high-dose chemotherapy before a stem cell transplant and patients undergoing radiotherapy for head and neck cancer (Zadik et al., Supportive Care in Cancer, 2019). This matters because a guideline recommendation from a specialist body is a much higher bar than a single positive study. It means multiple trials pointed the same way and a panel judged the evidence solid enough to act on.
Two other areas have a reasonable, if less settled, base. Musculoskeletal pain, particularly neck pain and some joint and tendon conditions, has been studied in placebo-controlled trials and meta-analyses, with several reporting short-term pain relief when the right wavelength and dose were used. Tissue and wound healing has similar support in the laboratory and in a number of clinical trials. In both cases the direction of the evidence is encouraging, though reviewers frequently note that results depend heavily on getting the treatment parameters right.
Where the Evidence Is Thinner
Now the part that a sales pitch would skip. The evidence for photobiomodulation in addiction and smoking cessation is far weaker than the evidence for mucositis or pain. It is preliminary.
The trials that exist tend to be small. Many test laser stimulation at acupuncture points rather than modern PBM protocols, which makes them hard to compare. Study designs vary so much, in wavelength, dose, points treated, and number of sessions, that pooling them into a clean conclusion is difficult. This variation is called heterogeneity, and it is one of the main reasons reviewers hesitate to make strong claims. On top of that, the field has a known publication bias problem: positive results get published and written up more readily than trials that found nothing, which can make a body of evidence look rosier than it is.
There is also the gap between mechanism and outcome mentioned earlier. It is reasonable to hypothesize that supporting cellular energy and endorphin activity could ease the neurochemical rough patch of early withdrawal. But "reasonable to hypothesize" is not "demonstrated in large, well-controlled cessation trials." That larger, cleaner evidence base does not yet exist for laser therapy and quitting. We say the same thing plainly in our fuller treatment of whether laser therapy to quit smoking works: there is real signal in the research, and there is also real uncertainty, and anyone who erases the second half is not being straight with you.
A Fair Summary Of Where Things Stand
The table below is a rough map, not a precise ranking. It reflects how much high-quality evidence exists, not a promise about any individual result.
| Use of photobiomodulation | State of the evidence |
|---|---|
| Oral mucositis in cancer care | Stronger. Supported by pooled reviews and specialist guidelines. |
| Musculoskeletal pain | Moderate. Several positive trials, results depend on dose and technique. |
| Wound and tissue healing | Moderate. Good laboratory basis and a body of clinical trials. |
| Addiction and smoking cessation | Preliminary. Small, varied studies, no large confirmatory trials yet. |
What should a cautious reader take from this? A few things. First, photobiomodulation is a genuine clinical tool with real evidence behind it in some fields, so it is not fair to dismiss it as pseudoscience. Second, that strength does not transfer automatically from one condition to another. Evidence for mouth ulcers does not prove anything about cravings. Third, in the areas where the research is still thin, the honest posture is measured optimism, not certainty, and you should be wary of anyone who offers you certainty.
What This Means If You Are Considering It To Quit
If you are looking at laser therapy as part of quitting smoking or vaping, hold two ideas at once. The mechanism is plausible and the safety profile is favourable, which is a reasonable footing to try something. At the same time, the cessation evidence has not yet reached the strength of the evidence in other PBM applications, so it should be treated as a support, not a proven cure, and never as a substitute for a real plan around your triggers.
That framing shapes how a responsible clinic should talk to you, and it is worth reading our how it works page with exactly this lens: does the language match the evidence, or does it overreach. Approaches with much larger evidence bases, such as nicotine replacement and certain prescription medications, remain legitimate options, and for many people the most sensible path combines physiological support with behavioural work rather than betting everything on one method.
If you decide it fits your situation, the practical side is straightforward and low pressure. There are zero upfront booking fees when you book a session. After you book, Meridee, the founder, reaches out personally by call or text to walk through the options, and any payment is verified at least 24 hours before your appointment, never at the door. You are not committing money to find out whether this is right for you.
Frequently Asked Questions
What does the research on photobiomodulation actually show?
It shows a genuine but uneven evidence base. Photobiomodulation has stronger support in areas like oral mucositis in cancer care, where specialist guidelines recommend it, and moderate support for some musculoskeletal pain and tissue healing. For addiction and smoking cessation the evidence is preliminary: small, varied studies without the large confirmatory trials that would settle the question.
Is photobiomodulation proven to help people quit smoking?
No, not in the way medications with large trial evidence are. The mechanism is plausible and early studies are encouraging, but the cessation research is limited by small samples, inconsistent methods, and likely publication bias. It is honest to call it a promising support rather than a proven cure, and to pair it with a plan for your habits and triggers.
Why is the evidence stronger for some conditions than others?
Because research accumulates unevenly. Oral mucositis attracted many well-designed trials that pointed the same direction, which let expert panels issue guidelines. Other uses, including cessation, have fewer and smaller studies that differ widely in wavelength, dose, and technique, so reviewers cannot yet draw firm conclusions. A plausible cell mechanism does not automatically produce strong clinical evidence.
Is cold laser therapy safe even if the evidence is still developing?
Photobiomodulation has a favourable safety profile because it is non-invasive, does not break the skin, and introduces nothing into the body. Safety and proven effectiveness are separate questions, though. A low risk of harm is a reasonable footing to try something, but it is not evidence that the treatment works for a given condition, and any clinic should keep those two things distinct.
Should I use laser therapy instead of nicotine replacement or medication?
Not necessarily instead. Nicotine replacement and some prescription medications have much larger evidence bases for cessation, and they are legitimate tools. Many people do best combining physiological support with behavioural change rather than relying on any single method. Talk to your doctor about the mix that fits you, especially if you have other health conditions or take prescribed medication.